Pfizer 2014 Annual Report Download - page 42

Download and view the complete annual report

Please find page 42 of the 2014 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 75

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75

PFIZER ANNUAL REVIEW 2014 www.pzer.com/annual 42
ANNUAL REVIEW 2014
Our Science > Research and Development
RESEARCH AND DEVELOPMENT
PIONEERING
NEW COLLABORATIONS
Just as science has advanced tremendously over the last decade, so has our
understanding of how we need to collaborate to advance innovation more quickly
and effectively. Our creative approach to external collaboration has resulted in new
types of arrangements with government, academia, patient advocacy groups and
the biomedical industry.
1,000+
ONGOING R&D COLLABORATIONS
WITH ACADEMIC MEDICAL CENTERS, GOVERNMENT
ORGANIZATIONS, NONPROFIT INSTITUTIONS, AND
PHARMACEUTICAL AND BIOTECH COMPANIES
WORLDWIDE AS OF DECEMBER 2014, INCLUDING
OVER 200 NEW R&D COLLABORATIONS IN 2014
“Pzer has a strong commitment to working
in rare diseases. However, the challenge
is too great for any one of us to go it alone.
Through innovative partnerships with both
academia and industry we hope to progress
gene therapy research and bring forth the
next generation of potential life-changing
therapies for patients living with
serious diseases.”
KEVIN LEE
CHIEF SCIENTIFIC
OFFICER
RARE DISEASE
RESEARCH UNIT
COLLABORATING
TO ACCELERATE
INNOVATION
READ MORE